Vimab Group AB Statistics
Total Valuation
Vimab Group AB has a market cap or net worth of SEK 107.01 million. The enterprise value is 184.32 million.
Important Dates
The next estimated earnings date is Friday, March 12, 2027.
| Earnings Date | Mar 12, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
Vimab Group AB has 47.56 million shares outstanding. The number of shares has decreased by -44.96% in one year.
| Current Share Class | 47.56M |
| Shares Outstanding | 47.56M |
| Shares Change (YoY) | -44.96% |
| Shares Change (QoQ) | +31.30% |
| Owned by Insiders (%) | 16.69% |
| Owned by Institutions (%) | 0.60% |
| Float | 25.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 540.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.59, with a Debt / Equity ratio of 481.68.
| Current Ratio | 0.59 |
| Quick Ratio | 0.38 |
| Debt / Equity | 481.68 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -21.63% |
| Return on Invested Capital (ROIC) | -50.71% |
| Return on Capital Employed (ROCE) | -2,872.70% |
| Weighted Average Cost of Capital (WACC) | 5.39% |
| Revenue Per Employee | 2.00M |
| Profits Per Employee | -496,571 |
| Employee Count | 176 |
| Asset Turnover | 1.49 |
| Inventory Turnover | 5.74 |
Taxes
| Income Tax | -505,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.18% in the last 52 weeks. The beta is -1.15, so Vimab Group AB's price volatility has been lower than the market average.
| Beta (5Y) | -1.15 |
| 52-Week Price Change | -43.18% |
| 50-Day Moving Average | 2.88 |
| 200-Day Moving Average | 2.96 |
| Relative Strength Index (RSI) | 23.45 |
| Average Volume (20 Days) | 13,556 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vimab Group AB had revenue of SEK 339.49 million and -84.42 million in losses. Loss per share was -3.71.
| Revenue | 339.49M |
| Gross Profit | 47.81M |
| Operating Income | -79.03M |
| Pretax Income | -84.92M |
| Net Income | -84.42M |
| EBITDA | -52.07M |
| EBIT | -79.03M |
| Loss Per Share | -3.71 |
Full Income Statement Balance Sheet
The company has 18.07 million in cash and 95.37 million in debt, with a net cash position of -77.30 million or -1.63 per share.
| Cash & Cash Equivalents | 18.07M |
| Total Debt | 95.37M |
| Net Cash | -77.30M |
| Net Cash Per Share | -1.63 |
| Equity (Book Value) | 198,000 |
| Book Value Per Share | 0.00 |
| Working Capital | -83.64M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -6.75 million and capital expenditures -1.75 million, giving a free cash flow of -8.51 million.
| Operating Cash Flow | -6.75M |
| Capital Expenditures | -1.75M |
| Depreciation & Amortization | 26.96M |
| Net Borrowing | 34.63M |
| Free Cash Flow | -8.51M |
| FCF Per Share | -0.18 |
Full Cash Flow Statement Margins
Gross margin is 14.08%, with operating and profit margins of -23.28% and -24.87%.
| Gross Margin | 14.08% |
| Operating Margin | -23.28% |
| Pretax Margin | -25.01% |
| Profit Margin | -24.87% |
| EBITDA Margin | -15.34% |
| EBIT Margin | -23.28% |
| FCF Margin | n/a |
Dividends & Yields
Vimab Group AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 44.96% |
| Shareholder Yield | 44.96% |
| Earnings Yield | -165.06% |
| FCF Yield | -7.95% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |